title: Induction treatment of light chain deposition disease with bortezomib: rapid hematological response with persistence of renal involvement.
authors: Jiri
authors: J
authors: Minarik
authors: Vlastimil
authors: V
authors: Scudla
authors: Tomas
authors: T
authors: Tichy
authors: Tomas
authors: T
authors: Pika
authors: Jaroslav
authors: J
authors: Bacovsky
authors: Pavel
authors: P
authors: Lochman
authors: Josef
authors: J
authors: Zadrazil
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001897:Boronic Acids / Q000627:therapeutic use*; D000069286:Bortezomib; D006801:Humans; D007676:Kidney Failure, Chronic / Q000209:etiology* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000150:complications / Q000188:drug therapy*; D011379:Prognosis; D011507:Proteinuria / Q000209:etiology / Q000473:pathology; D011719:Pyrazines / Q000627:therapeutic use*; D012074:Remission Induction
chemical_list: D000970:Antineoplastic Agents; D001897:Boronic Acids; D011719:Pyrazines; D000069286:Bortezomib